Cited 0 times in Scipus Cited Count

Role of Amino Acid 926-977 in Drosophila PERIOD Protein for Circadian Clockworks

DC Field Value Language
dc.contributor.advisor김, 은영-
dc.contributor.author선, 우철-
dc.date.accessioned2011-04-13T05:33:35Z-
dc.date.available2011-04-13T05:33:35Z-
dc.date.issued2010-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/2268-
dc.description.abstract생체시계의 분자적 기전은 transcriptional-translational feedback loop이다. 초파리 feedback loop의 첫 번째 loop에서는 bHLH/PAS 도메인을 함유한 전사인자인 dCLOCK (dCLK) 과 CYCLE (CYC) 가 dperiod (dper)와 timeless (tim) 의 발현을 촉진하고 합성된 dPER 단백질과 TIM 단백질이 이합체로 결합하여 dCLK/CYC의 전사활성을 억제하여 dper 와 tim 의 발현이 하루를 주기로 진동케 한다. 여기에는 dPER에 의한 dCLK/CYC 전사활성의 억제가 필수적이다. 본 연구에서는 dPER에서 dCLK/CYC의 전사활성을 억제하는데 필요한 도메인으로 알려진 dCLK CYC inhibition domain (CCID) 에서 특히 종간 보존성이 매우 높은 아미노산 926-977 부분의 역할을 탐구하였다. dPER로부터 아미노산 926-977 을 제거한 변이체인 dPER(Δ926-977) 은 초파리 세포라인 Schneider 2 (S2) 세포에서 dCLK/CYC의 전사활성을 억제하지 못하였다. dPER(Δ926-977) 는 dCLK과 결합하지 못하였는데, 이로부터 아미노산 926-977이 dCLK의 binding domain 으로 작용한다는 사실을 밝혀내었다. 더욱이 아미노산 949-977만을 내부적으로 제거한 dPER(Δ949-977) 가 S2 세포에서 dCLK/CYC의 전사활성을 억제하지 못하고 dCLK과의 결합능력이 떨어지는 것으로 보아 아미노산 949-977이 dCLK과의 결합에 필요한 최소 도메인인 것을 확인하였다. 아미노산 926-977의 in vivo 역할을 탐색하기 위하여 dPER(Δ926-977)를 발현시키는 초파리를 제작하였고, 이 초파리의 생체리듬을 분석하여 본 결과 주기가 길어지기는 하였으나 정상적인 생체리듬을 갖는 것을 알 수 있었다. dCLK의 결합에 필수적인 아미노산 926-977이 없는 dPER가 in vivo 에서 생체시계 유전자의 발현이 진동하게 하는 feedback loop작동에 정상적인 기능을 한다는 사실은 매우 흥미로우며 이에 대한 후속 연구가 진행되어야 할 것으로 보인다.-
dc.description.tableofcontents"국문요약 ····················································································································· ⅰ

차례 ····························································································································· ⅲ

그림 차례 ··················································································································· ⅴ

표 차례 ······················································································································· ⅶ

Ⅰ. 서론 ························································································································ 1

Ⅱ. 재료 및 방법 ········································································································ 8

A. Plasmid ················································································································ 8

1. Site-direct mutagenesis를 이용하여 만든 plasmid들 ································· 8

2. Rapid and efficient PCR-based mutagenesis를 이용하여 만든 plasmid들

(Ko 와 Ma, 2005) ···························································································· 8

3. Cloning으로 만든 plasmid들 ········································································ 8

4. 참고문헌을 통해 이미 사용되어 인용된 plasmid들 ······························· 8

B. Site-direct mutagenesis ························································································ 9

1. QuickChange site-directed mutagenesis kit ···················································· 9

2. Site-directed mutagenesis를 위한 primer ···················································· 10

3. Rapid and efficient PCR-based mutagenesis method (Ko 와 Ma, 2005) ······ 11

4. PCR-based Rapid site directed mutagenesis를 위한 Primer들 ··················· 13

C. Drosophila melanogaster Schneider line 2 (S2) 세포의 배양과transfection

······························································································································· 15

iv

D. 형질전환 초파리 (Transgenic Drosophila melanogaster) ···························· 16

E. Locomotor activity assays ·················································································· 17

F. Immunoblot analysis ·························································································· 18

G. Immunoprecipitation (IP) ·················································································· 21

H. Luciferase Reporter Assay 와 β-Galactosidase Enzyme Assay System ········· 23

Ⅲ. 결과 ······················································································································ 25

A. S2 세포에서 dPERΔ926-977은 dCLK의 전사활성을 억제하지 못한다

····························································································································· 25

B. S2 cells에서 dPERΔ926-977은 dCLK과 결합하지 못한다 ········ 28

C. dPERΔ926-977은 DBT에 의한 인산화에 결함을 나타내었다 ····· 32

D. 아미노산 949-977이 dCLK과의 결합에 필요한 최소 도메인이다 ····· 34

E. dPER의 아미노산949-977를 Ser과 Thr을 모두 Ala으로 바꾸어도

DBT에 의한 인산화가 일어난다 ································································ 38

F. dPERΔ926-977을 발현하는 형질전환 초파리는 주기가 길어지기는

하였으나 정상적인 생체리듬을 가졌다 ···················································· 43

Ⅳ. 고찰 ······················································································································ 46

Ⅴ. 결론 ······················································································································ 48

참고문헌 ····················································································································· 50

ABSTRACT ················································································································ 53"
-
dc.language.isoko-
dc.titleRole of Amino Acid 926-977 in Drosophila PERIOD Protein for Circadian Clockworks-
dc.title.alternative초파리 PERIOD 단백질의 아미노산 926-977이 생체시계의 작동에 관여하는 분자적 기전-
dc.typeThesis-
dc.identifier.urlhttp://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000010906-
dc.subject.keyword초파리-
dc.subject.keyword생체시계-
dc.subject.keyworddPERIOD-
dc.subject.keyworddCLOCK-
dc.subject.keyword전사활성-
dc.subject.keyword인산화-
dc.description.degreeMaster-
dc.contributor.department대학원 의생명과학과-
dc.contributor.affiliatedAuthor선, 우철-
dc.date.awarded2010-
dc.type.localTheses-
dc.citation.date2010-
dc.embargo.liftdate9999-12-31-
dc.embargo.terms9999-12-31-
Appears in Collections:
Theses > Graduate School of Biomedical Sciences > Master
Files in This Item:
There are no files associated with this item.

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse